4-carbamoyl-2-(6-methoxy-4H-quinazolin-3-yl)butanoic acid → 3-(6-methoxy-4H-quinazolin-3-yl)piperidine-2,6-dione
Reaction equation
[C:1]([CH2:4][CH2:5][CH:6]([N:10]1[CH2:19][C:18]2[C:13](=[CH:14][CH:15]=[C:16]([O:20][CH3:21])[CH:17]=2)[N:12]=[CH:11]1)[C:7](O)=[O:8])(=[O:3])[NH2:2]>C(OC(=O)C)(=O)C.C(Cl)(=O)C>[CH3:21][O:20][C:16]1[CH:17]=[C:18]2[C:13](=[CH:14][CH:15]=1)[N:12]=[CH:11][N:10]([CH:6]1[CH2:5][CH2:4][C:1](=[O:3])[NH:2][C:7]1=[O:8])[CH2:19]2Participants
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
A solution of 1.20 g of the crude product from stage 4 in 7 ml of acetic anhydride and 7 ml of acetyl chloride was stirred for 5 hours at 70° C. and then concentrated by evaporation in vacuo. The residue was taken up in 20 ml of methanol and stirred for 1 hour with Amberlyst A-21 ion exchanger. After filtration the filtrate was concentrated by evaporation in vacuo and the residue was purified by flash chromatography with chloroform/methanol (4/1) as eluent. The free base of the title compound thereby obtained was dissolved in 4 ml of methanol and 0.5 ml of a saturated solution of HCl gas in diethyl ether followed by 150 ml of diethyl ether were added to the solution. The salt formed was separated and dried in vacuo, 0.29 g (23% of theory referred to L-glutamine in stage 4) of the title compound being obtained.
Workup
- concentrationconcentrated by evaporation in vacuo
- filtrationAfter filtration the filtrate
- concentrationwas concentrated by evaporation in vacuo
- customthe residue was purified by flash chromatography with chloroform/methanol (4/1) as eluent
Sources & evidence
- ORD record
- ord-a98e9f362e844bee916efb41db14eeeb
- Source dataset
- uspto-grants-2007_02
- Patent number
- US07183274B2
Reaction notes
Loading…